Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank First oral treatment for spinal muscular atrophy (SMA) recommended for approval 26 February 2021NewsHumanMedicines Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers 25 February 2021NewsHumanCOVID-19Regulatory and procedural guidanceVaccines International cooperation to align approaches for regulation of COVID-19 vaccines and medicines 25 February 2021NewsHumanCOVID-19MedicinesVaccines EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19 24 February 2021NewsHumanCOVID-19Medicines EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen 23 February 2021NewsHumanCOVID-19 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 2021 19 February 2021NewsVeterinaryMedicines Precautionary marketing suspension of thalassaemia medicine Zynteglo 17 February 2021News EMA receives application for conditional marketing authorisation of COVID-19 Vaccine Janssen 16 February 2021NewsHumanCOVID-19MedicinesVaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021 12 February 2021NewsHumanCOVID-19PharmacovigilanceReferrals EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV) 12 February 2021NewsHumanCOVID-19MedicinesVaccines 1 … 67 68 69 70 71 Page 71 of 380 72 73 74 75 … 380
First oral treatment for spinal muscular atrophy (SMA) recommended for approval 26 February 2021NewsHumanMedicines
Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers 25 February 2021NewsHumanCOVID-19Regulatory and procedural guidanceVaccines
International cooperation to align approaches for regulation of COVID-19 vaccines and medicines 25 February 2021NewsHumanCOVID-19MedicinesVaccines
EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19 24 February 2021NewsHumanCOVID-19Medicines
EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen 23 February 2021NewsHumanCOVID-19
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 2021 19 February 2021NewsVeterinaryMedicines
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine Janssen 16 February 2021NewsHumanCOVID-19MedicinesVaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021 12 February 2021NewsHumanCOVID-19PharmacovigilanceReferrals
EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV) 12 February 2021NewsHumanCOVID-19MedicinesVaccines